Comments
Loading...
Sage Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SAGE | Benzinga
Sage Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 24
EPS Estimate
$-1.220
Quarterly Revenue Estimate
$15.27M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$41.24M
Analyze the earnings history of Sage Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics | -$1.80 | -$1.22 | — | — | $7.90M | $15.27M | — | — | 04/24/2025 | Get Alert |
| SAGE | Sage Therapeutics | -$0.55 | -$1.36 | -$1.56 | -14.71% | $77.97M | $14.37M | $12.81M | -10.82% | 02/11/2025 | Get Alert |
| SAGE | Sage Therapeutics | -$3.37 | -$1.53 | -$1.53 | 0.00% | $2.72M | $10.80M | $11.87M | 9.92% | 10/29/2024 | Get Alert |
| SAGE | Sage Therapeutics | -$2.68 | -$1.66 | -$1.70 | -2.41% | $2.47M | $8.85M | $8.65M | -2.19% | 07/31/2024 | Get Alert |
| SAGE | Sage Therapeutics | -$2.46 | -$1.65 | -$1.80 | -9.09% | $3.29M | $5.66M | $7.90M | 39.61% | 04/25/2024 | Get Alert |
| SAGE | Sage Therapeutics | -$2.47 | -$1.28 | -$0.55 | 57.03% | $2.87M | $60.98M | $77.97M | 27.86% | 02/14/2024 | Get Alert |
| SAGE | Sage Therapeutics | -$2.31 | -$2.73 | -$3.37 | -23.44% | $1.74M | $4.62M | $2.72M | -41.21% | 11/07/2023 | Get Alert |
| SAGE | Sage Therapeutics | -$2.13 | -$2.55 | -$2.68 | -5.10% | $1.50M | $2.94M | $2.47M | -15.85% | 08/07/2023 | Get Alert |
| SAGE | Sage Therapeutics | -$2.07 | -$2.50 | -$2.46 | 1.60% | $1.58M | $2.41M | $3.29M | 36.68% | 05/02/2023 | Get Alert |
| SAGE | Sage Therapeutics | -$2.12 | -$2.39 | -$2.47 | -3.35% | $1.64M | $1.94M | $2.87M | 47.68% | 02/16/2023 | Get Alert |
| SAGE | Sage Therapeutics | -$2.21 | -$2.21 | -$2.31 | -4.52% | $1.44M | $1.64M | $1.74M | 6.04% | 11/08/2022 | Get Alert |
| SAGE | Sage Therapeutics | -$1.83 | -$2.15 | -$2.13 | 0.93% | $1.64M | $1.76M | $1.50M | -14.72% | 08/02/2022 | Get Alert |
| SAGE | Sage Therapeutics | -$1.64 | -$2.04 | -$2.07 | -1.47% | $1.58M | $3.21M | $1.58M | -50.72% | 05/03/2022 | Get Alert |
| SAGE | Sage Therapeutics | $18.19 | -$2.17 | -$2.12 | 2.30% | $1.11B | $1.97M | $1.64M | -16.65% | 02/24/2022 | Get Alert |
| SAGE | Sage Therapeutics | -$2.03 | -$1.85 | -$2.21 | -19.46% | $1.64M | $1.96M | $1.44M | -26.53% | 11/02/2021 | Get Alert |
| SAGE | Sage Therapeutics | -$2.08 | -$1.69 | -$1.83 | -8.28% | $1.09M | $2.01M | $1.64M | -18.26% | 08/03/2021 | Get Alert |
| SAGE | Sage Therapeutics | -$2.44 | -$1.91 | -$1.64 | 14.14% | $2.29M | $2.00M | $1.58M | -20.85% | 05/04/2021 | Get Alert |
| SAGE | Sage Therapeutics | -$3.25 | -$0.35 | $18.19 | 5297.14% | $1.96M | $55.34M | $1.11M | -98.00% | 02/24/2021 | Get Alert |
| SAGE | Sage Therapeutics | -$3.48 | -$2.39 | -$2.03 | 15.06% | $3.57M | $1.86M | $1.64M | -11.88% | 11/05/2020 | Get Alert |
| SAGE | Sage Therapeutics | -$3.28 | -$2.66 | -$2.08 | 21.80% | $873.00K | $890.00K | $1.09M | 22.36% | 08/10/2020 | Get Alert |
| SAGE | Sage Therapeutics | -$3.37 | -$3.14 | -$2.44 | 22.29% | $465.00K | $2.80M | $2.29M | -18.36% | 05/07/2020 | Get Alert |
Sage Therapeutics (SAGE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-11 | $-1.56 | $-1.36 | -14.7 % |
| Q3 | 2024-10-29 | $-1.53 | $-1.53 | 0.00 % |
| Q2 | 2024-07-31 | $-1.70 | $-1.66 | -2.41 % |
| Q1 | 2024-04-25 | $-1.80 | $-1.65 | -9.09 % |
Sage Therapeutics (SAGE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-11 | $12.82M | $14.37M | -10.8 % |
| Q3 | 2024-10-29 | $11.87M | $10.80M | 9.92 % |
| Q2 | 2024-07-31 | $8.65M | $8.85M | -2.19 % |
| Q1 | 2024-04-25 | $7.90M | $5.66M | 39.6 % |
FAQ
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics (SAGE) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Sage Therapeutics (NASDAQ:SAGE)?
The Actual EPS was $-1.56, which missed the estimate of $-1.36.
What were Sage Therapeutics’s (NASDAQ:SAGE) revenues?
The Actual Revenue was $12.8M, which missed the estimate of $14.4M.
Browse earnings estimates, EPS, and revenue on all stocks.